Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia

被引：3
|
作者：
Beauclair, L
Lam, A
McCormick, J
Luong, D
Camacho, F
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Janssen Ortho Inc, Toronto, ON, Canada
[3] McKesson Phase 4 Solut, Toronto, ON, Canada
[4] Damos Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67769-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A202 / A203
页数：2
相关论文
共 50 条
  • [41] Comparison of Subjective Experiences and Effectiveness of First-Generation Long-Acting Injectable Antipsychotics and Risperidone Long-Acting Injectables in Patients With Schizophrenia
    Chen, Wen-Yin
    Lin, Shih-Ku
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (05) : 492 - 495
  • [42] Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
    Apostolos Aidonopoulos
    Anastasios Kanistras
    Anastasia Karastergiou
    Athanasios Karavatos
    Konstantinos Katsafouros
    Konstantinos Kontis
    Venetsanos Mavreas
    Maria Tzanakaki
    Nikolaos Tzavaras
    Errikos Tzebelikos
    Annals of General Psychiatry, 5 (Suppl 1)
  • [43] Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia
    Lindenmayer, Jean-Pierre
    Khan, Anzalee
    SCHIZOPHRENIA RESEARCH, 2011, 125 (2-3) : 267 - 277
  • [44] Two years follow up study with long-acting injectable risperidone in schizophrenia
    Chinchilla, A.
    Vega, M.
    Crespo, D.
    Yanez, R.
    Pando, F.
    Benitez, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 155 - 156
  • [45] Haloperidol decanoate and long-acting injectable risperidone: subjective experience of outpatients with schizophrenia
    Dalmotto, M.
    Pirfo, E.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2010, 16 (03): : 299 - 304
  • [46] A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
    Li, Huafang
    Rui, Qing
    Ning, Xiaoping
    Xu, Haiyan
    Gu, Niufan
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (04): : 1002 - 1008
  • [47] Hospitalization risk in patients with schizophrenia before and after initiation of risperidone long-acting injection in Japan
    Yoshimura, Bunta
    Shinkawa, Ikuta
    Konishi, Akiko
    ASIAN JOURNAL OF PSYCHIATRY, 2015, 14 : 67 - 68
  • [48] Long-acting injectable antipsychotic medication after a first episode of schizophrenia
    不详
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 : 7 - 7
  • [49] Use of long-acting risperidone
    Pinninti, NR
    Mago, R
    PSYCHIATRIC SERVICES, 2005, 56 (01) : 105 - 105
  • [50] Rationale for the use of long-acting injectable risperidone: A survey of French psychiatrists
    Misdrahi, D.
    Delgado, A.
    Bouju, S.
    Comet, D.
    Chiariny, J. -F.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2013, 39 : S8 - S14
12345